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The receptive field of the TRPA1 nociceptor is remarkably expansive when compared to other
chemodetectors such as odorant receptors. The identification of a unique mechanism utilized by
TRPA1 helps clarify how this protein can efficiently alert the cell to an array of reactive chemical
agents, regardless of their structure.The olfactory, gustatory, and trigeminal systems, known
collectively as the ‘‘chemical senses,’’ work in concert to
detect chemicals in the environment. Indeed, these sys-
tems respond to many of the same compounds. However,
the mechanisms employed by the various chemorecep-
tors within each system can be strikingly different, resulting
in pronounced effects on receptor physiology and giving
rise to experiences as disparate as the ephemeral per-
ception of a lilac and the persistent tears from a sliced
onion.
Odorant receptors often exhibit great sensitivity to nu-
ances in the chemical structure of their ligands. Adding
or subtracting a single carbon or shifting the location of
a double bond can profoundly affect whether or not a com-
pound is an effective agonist, as demonstrated by the
markedly different responses to hexanal (Figure 1, 1)
versus heptanal (Figure 1, 2) at rat OR-I7 (Araneda et al.,
2000) and eugenol (Figure 1, 4) versus isoeugenol (Figure 1,
5) at mOR-EG (Kajiya et al., 2001). Thus, highly related
chemicals typically populate the receptive field of a mam-
malian odorant receptor (Araneda et al., 2000; Gaillard
et al., 2002; Spehr et al., 2003). In contrast, the range
of compounds that activate the trigeminal nociceptor
TRPA1 is staggeringly diverse—including plant-derived
allylic mono-, di-, and trisulfides (Bautista et al., 2005;
Macpherson et al., 2005), isothiocyanates (Bandell et al.,
2004; Jordt et al., 2004), and a,b-unsaturated aldehydes
(Bandell et al., 2004; Bautista et al., 2006). Despite being
able to recognize a host of both aliphatic and aromatic
compounds, TRPA1 simultaneously displays a surprising
level of discrimination. For example, TRPA1 is readily acti-
vated by acrolein (a.k.a. trans-2-propenal [Figure 1, 8]) but
is insensitive to the corresponding saturated aldehyde,
propanal (Figure 1, 7; Bautista et al., 2006).
Two recent papers (Hinman et al., 2006; Macpherson
et al., 2007) help reconcile this paradox by highlighting
that the chemical reactivity and not structure per se is the
critical feature of many TRPA1 agonists. These agonists,
through a variety of functional groups, all possess an elec-
trophilic carbon or sulfur that is subject to nucleophilic
attack by the sulfur in cysteine side chains of TRPA1. The
ability of benzyl isothiocyanate (Figure 1, 12; a strong elec-
trophile) but not benzyl thiocyanate (Figure 1, 13; a weaker
electrophile of nearly identical shape) to activate TRPA1elegantly underscores this phenomenon (Hinman et al.,
2006). Thus, while odorant receptors can readily distin-
guish between enantiomers of carvone (Figure 1, 25;
Hamana et al., 2003), one would predict that electrophile
stereoisomers differing only in their chirality or cis/trans
arrangement should be equally effective at the TRPA1
nociceptor.
However, TRPA1’s novel method of activation comes
with a substantial tradeoff in terms of receptor kinetics.
Odorant receptors such as mOR-EG recognize their li-
gands though transient, weak intermolecular interactions
within a more traditional binding pocket (Katada et al.,
2005). While they may have a more narrowly tuned recep-
tive field, odorant receptors can respond repeatedly to
multiple applications of an agonist with fair temporal fidel-
ity. In contrast, the reaction with an electrophilic com-
pound that underlies TRPA1’s ability to detect such an ex-
panded array of agents leaves a covalently linked adduct
on the receptor. This modification of the protein persists
for hours as monitored by reacting fluorescent tags with
alkyne groups engineered into the electrophile (Macpher-
son et al., 2007). In consequence, the physiological re-
sponse of TRPA1 to electrophiles is greatly prolonged
as the compound cannot dissociate and the receptor
remains activated. Experimentally, currents elicited by
N-methyl maleimide (NMM; Figure 1, 14; Hinman et al.,
2006) and cinnamaldehyde (Figure 1, 10; Bandell et al.,
2004) last well beyond the stimulus duration, and the ele-
vation in intracellular calcium in response to a cinnamalde-
hyde analog only gradually diminishes over the course of
an hour (Macpherson et al., 2007). TRPA1 is thus greatly
limited in its ability to respond to a closely timed second
pulse of such electrophilic agonists.
While these covalent modifications pose unique chal-
lenges to signal termination within the cell, they can be
exploited as a tool to directly identify which cysteines in
TRPA1 are most reactive with a given electrophile.
Macpherson et al. combined click chemistry (Speers
et al., 2003) with protein degradation and mass spectrom-
etry to empirically determine which amino acid residues
react with an alkynated variant of the electrophile iodoace-
tamide (Figure 1, 15). Surprisingly, the critical cysteines re-
side within the intracellular N terminus of mouse TRPA1.
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served cysteines.
An important consequence of an intracellular site of ac-
tion is that the EC50 for such TRPA1 agonists, when as-
sayed by whole-cell methods, reflects a combination of
the electrophile strength and the compound’s membrane
permeability. Indeed, this effect was dramatically illus-
trated by comparison of the two highly similar electro-
philes MTSEA (Figure 1, 16) and MTSET (Figure 1, 17).
Both possess the same reactive thiosulfonate group and
Figure 1. A Sampling of the Receptive Field of Two Odorant
Receptors (Rat OR-I7 and Mouse mOR-EG) and the
Nociceptor TRPA1
Key: black = active; gray = inactive, unknown inhibitory status; blue =
inactive, demonstrated inhibitory; red asterisk = electrophilic atom.
Chemical names: (1) hexanal; (2) heptanal; (3) trans-2-heptenal; (4)
eugenol; (5) isoeugenol; (6) diallyl disulfide; (7) propanal; (8) acrolein/
trans-2-propenal; (9) trans-2-pentenal; (10) trans-cinnamaldehyde;
(11) allyl isothiocyanate/AITC; (12) benzyl isothiocyanate; (13) benzyl
thiocyanate; (14) N-methyl maleimide/NMM; (15) iodoacetamide
alkyne; (16) MTSEA; (17) MTSET; (18) D9-tetrahydrocannabinol/THC;
(19) HU-210; (20) gingerol; (21) capsaicin; (22) carvacrol; (23) L-menthol;
(24) ()-isopulegol; (25) L-carvone.636 Neuron 53, March 1, 2007 ª2007 Elsevier Inc.would likely elicit similar effects in excised inside-out
patch recordings. However, the change from an amine
to a charged trimethyl ammonium group renders MTSET
membrane impermeable and wholly ineffective as an ago-
nist in TRPA1-expressing oocytes (Hinman et al., 2006).
How the details of the detection mechanism shape the
response profile of a chemoreceptor can be seen in a com-
parison between TRPA1 and the rat OR-I7 odorant recep-
tor. The seven carbon long trans-2-alkenal (Figure 1, 3) is
a robust OR-I7 agonist (Araneda et al., 2000), and TRPA1
is likewise potently activated by similar three (Figure 1, 8)
and five (Figure 1, 9) carbon trans-2-alkenals (Bautista
et al., 2006). However, OR-I7 and TRPA1 relay very differ-
ent information about such aldehydes. OR-I7 demon-
strates little regard for the electrophilic nature of the alde-
hyde (Figure 1, compare 2 versus 3), but it does exhibit
a clear length preference for 7–11 carbon trans-2-alkenals
(Araneda et al., 2000). This trend reflects steric constraints
within a more traditional binding pocket (Hall et al., 2004),
and it would result in a graph of EC50 versus carbon num-
ber with an abruptly appearing, bell-shaped distribution
for panel members tested on OR-I7. For TRPA1, however,
the critical feature of trans-2-alkenals is that they share the
same reactive electrophilic group. Based on electrophilic-
ity alone, all members of a panel of trans-2-alkenals, re-
gardless of length, should activate TRPA1. But since in-
creasing the alkyl tail length also gradually increases the
hydrophobicity of the compound (enabling it to more read-
ily enter the cell), one would thus expect an inverse linear
relationship between EC50 and carbon number without
evidence of cutoff for panel members tested at TRPA1.
The response profiles of these two chemoreceptors thus
reflect the specialized demands of their respective sys-
tems: discriminating between specific chemical shapes
for olfaction and detecting reactive and potentially
damaging chemicals for nociception.
An additional explanation for the unusually diverse re-
ceptive field of TRPA1 has also emerged through the
study of mutant versions of TRPA1. Unlike odorant recep-
tors, which have a single predicted odorant-binding
pocket, TRPA1 appears to possess at least one other
and possibly multiple other chemical detection sites. Mu-
tating just one or a few particular cysteines to nonreactive
serines or alanines was sufficient to render TRPA1 insen-
sitive to most electrophiles (Hinman et al., 2006; Macpher-
son et al., 2007) regardless of their exact functional group.
However, the mutant channels could still be activated
by several nonelectrophilic compounds such as icilin
(Macpherson et al., 2007). The currents elicited by these
nonelectrophilic agonists are rapidly reversible (Jordt
et al., 2004; Macpherson et al., 2007; Xu et al., 2006), sug-
gesting that the alternate chemical detection site(s) more
closely resembles a traditional binding pocket that only
transiently interacts with appropriate ligands.
The nature of these noncovalently interacting site(s)
within TRPA1 is still poorly understood.D9-tetrahydrocan-
nabinol (THC; Figure 1, 18) is a large heterocyclic plant-
derived compound that can be detected even in TRPA1
Neuron
Minireviewcysteine mutants that no longer respond to electrophiles.
A number of other, smaller plant-derived compounds such
as eugenol (Figure 1, 4) and carvacrol (Figure 1, 22) can
activate wild-type TRPA1 as well (Bandell et al., 2004).
Although not yet tested in the TRPA1 cysteine mutants,
these compounds are also likely detected by a secondary
mechanism since the electrophile AITC (Figure 1, 11) can
still elicit a moderate current following prior desensitizing
pulses of carvacrol (Xu et al., 2006), similar to how AITC
can trigger a large additional increase in intracellular cal-
cium following prolonged prior application of THC (Jordt
et al., 2004). These nonelectrophilic agonists happen to
share a phenol core. However, this feature alone is insuf-
ficient to account for their effects, since it is also present in
two compounds to which TRPA1 is insensitive: HU-210
(Figure 1, 19; Jordt et al., 2004) and capsaicin (Figure 1,
21; Macpherson et al., 2006). Interestingly, eugenol (Fig-
ure 1, 4) is also an agonist of the odorant receptor mOR-
EG. In that system, an array of related small aromatic
compounds has been used to probe the structural and
functional requirements of both agonists and antagonists
and how they relate to mOR-EG’s binding pocket (Katada
et al., 2005). Assaying TRPA1 with these compounds
could prove a fruitful start to characterizing the apparently
more traditional eugenol-binding site present in this
nociceptor.
But while plants can trigger nociception by activating
TRPA1 with both electrophilic and nonelectrophilic com-
pounds, they also have provided at least a temporary
balm in the form of menthol (Figure 1, 23). Menthol can
inhibit both the current and elevated intracellular calcium
induced by electrophiles at TRPA1 (Macpherson et al.,
2006, 2007). However, the rapid reversibility of this inhibi-
tion shows that menthol merely masks the consequences
of electrophile interactions with TRPA1; little if any change
would be expected in the levels of covalently modified
TRPA1 upon menthol treatment. In contrast, the cell per-
meable reducing agent dithiothreitol eliminates the adduct
and leads to a sustainable decrease in intracellular cal-
cium levels by breaking the covalent disulfide bond
formed between the cysteine and electrophilic sulfur in
compounds such as MTSEA (Figure 1, 16; Macpherson
et al., 2007). Whether menthol can also inhibit the re-
sponses elicited by either THC-like or eugenol-like non-
electrophile agonists has not been determined. However,
menthol’s ability to also inhibit TRPA1’s activation by cold
(Macpherson et al., 2006) suggests that this compound
may be an allosteric modulator with a more global effect
on protein structure or gating.
A number of chemicals structurally related to menthol
do not activate TRPA1 (Bandell et al., 2004), but whether
they too have inhibitory effects has not yet been tested.
One particular compound, carvone (Figure 1, 25), will be
particularly intriguing to revisit; although it shares several
structural features with menthol (Figure 1, 23) and isopule-
gol (Figure 1, 24), it also possesses an electrophilic car-
bon. L-carvone was unable to activate TRPA1 when
bath applied in a FLIPR assay (Bandell et al., 2004).However, whether any activation would surface
following washout of the initial pulse and whether the
D-enantiomer of carvone behaves any differently has not
been reported. The methyl group on the a carbon of car-
vone does somewhat decrease its electrophilicity. Is car-
vone, like benzyl thiocyanate (Figure 1, 13), too poor an
electrophile to substantially activate TRPA1? Or can car-
vone simultaneously inhibit its own induced current? Or
is L-carvone sufficiently dissimilar to menthol that it would
be unable to inhibit activation by even strong electro-
philes? A careful dissection of the action of carvone could
provide a fascinating glimpse of how TRPA1 integrates in-
formation from its multiple chemodetection mechanisms.
So, how does all this chemistry translate into a sensory
experience? TRPA1 is a nonselective cation channel ex-
pressed in subsets of nociceptors of the dorsal root and
trigeminal neurons. Presumably, the channel localizes to
free nerve endings in the skin and mouth that, when depo-
larized, ultimately result in the sensation of pain. Thus,
components of mustard (Figure 1, 11), cinnamon (Figure 1,
10), and garlic (Figure 1, 6), as well as environmental irri-
tants such as those found in smoke (Figure 1, 8), elicit a
common painful sensation by directly triggering TRPA1.
However, natural compounds are not the only way to
open the channel. TRPA1 is also critical for sensing inflam-
matory hyperalgesia (Bautista et al., 2006) and has a puta-
tive role in mechanosensation (Kwan et al., 2006). The
channel is modulated by the activity of other receptors, in-
cluding the TRPV1 (heat) and B2R (bradykinin) receptors
(Bandell et al., 2004; Bautista et al., 2006), through intra-
cellular signaling pathways. Intracellular Ca2+ sensitivity
is conferred by an EF motif in the N terminus of TRPA1.
While noxious cold was the first reported method of acti-
vating TRPA1 (<17C; Story et al., 2003), it now appears
that this effect is due to alterations in intracellular Ca2+
levels (Zurborg et al., 2007).
In sum, TRPA1 is a polymodal node that translates
diverse hostilities into a singular experience. As we know
the world through the filter of our sensory systems, we
have no choice but to assume their fidelity. Natural com-
pounds found in plants have particularly ingenious
ways of ‘‘TRPing’’ these channels to create chemical
illusions. We, in turn, have commandeered these com-
pounds as instruments to improve our understanding of
our sensory systems and, more importantly, our culinary
experience.
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